Skip to main content
Catherine Pisano, MD, Dermatology, Boston, MA

CatherineEvelynPisanoMD

Dermatology Boston, MA

Dermatologic Surgery

Physician

Dr. Pisano is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Pisano's full profile

Already have an account?

  • Office

    45 Francis Street
    Boston, MA 02115

Summary

  • Dr. Catherine Pisano is a Mohs micrographic surgeon and cutaneous oncologist at Brigham and
    Women's Hospital/Dana-Farber Cancer Institute/Harvard Medical School. She received her medical degree from Louisiana State University School of Medicine, completed her dermatology residency at The University of Texas at Austin, completed a cutaneous oncology fellowship at Harvard Medical School, and completed her Mohs micrographic surgery fellowship at Columbia University.

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Fellowship, Micrographic Surgery and Dermatologic Oncology, 2022 - 2023
  • Harvard Medical School
    Harvard Medical SchoolResidency, 2022
  • University of Texas at Austin Dell Medical School
    University of Texas at Austin Dell Medical SchoolResidency, Dermatology, 2018 - 2021
  • Louisiana State University School of Medicine in New Orleans
    Louisiana State University School of Medicine in New OrleansClass of 2017

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2021 - 2025
  • NY State Medical License
    NY State Medical License 2022 - 2024
  • American Board of Dermatology Dermatology

Publications & Presentations

PubMed

Press Mentions

  • How to Protect Your Skin from Sun Damage and Cancer
    How to Protect Your Skin from Sun Damage and CancerJuly 3rd, 2024